MRK - Merck & Co Inc
77.23
| Index: | DJIA, S&P 500 | P/E: | 11.24 | EPS (ttm): | 6.87 | Insider Own: | 0.10% | Shs Outstand: | 2.52B | Perf Week: | -3.98% |
| Market Cap: | 193.93B | Forward P/E: | 7.94 | EPS next Y: | 9.72 | Insider Trans: | -0.13% | Shs Float: | 2.51B | Perf Month: | -0.99% |
| Income(ttm): | 17.43B | PEG: | 0.97 | EPS next Q: | 2.06 | Inst Own: | 80.30% | Short Float: | 1.48% | Perf Quarter: | -7.28% |
| Revenue(ttm): | 63.78B | P/S: | 3.04 | EPS this Y: | 16.48% | Inst Trans: | 1.32% | Short Ratio: | 2.17 | Perf Half Y: | -21.59% |
| Book/sh: | 19.21 | P/B: | 4.02 | EPS next Y: | 9.10% | ROA: | 15.78% | Short Interest: | 37.14M | Perf Year: | -41.37% |
| Cash/sh: | 3.72 | P/C: | 20.78 | EPS next 5Y: | 11.65% | ROE: | 39.31% | 52W Range: | 73.31 - 134.63 | Perf YTD: | -22.37% |
| Dividend Est.: | 3.14 (4.07%) | P/FCF: | 11.38 | EPS past 5Y: | 12.04% | ROI: | 21.31% | 52W High: | -42.64% | Beta: | 0.38 |
| Dividend TTM: | 3.16 (4.09%) | Quick Ratio: | 1.16 | Sales past 5Y: | 7.14% | Gross Margin: | 74.68% | 52W Low: | 5.35% | ATR (14): | 2.70 |
| Dividend Ex-Date: | Mar 17, 2025 | Current Ratio: | 1.41 | EPS Y/Y TTM: | 654.93% | Oper. Margin: | 34.71% | RSI (14): | 43.95 | Volatility: | 3.98% 3.16% |
| Employees: | 75000 | Debt/Eq: | 0.72 | Sales Y/Y TTM: | 4.40% | Profit Margin: | 27.33% | Recom: | 1.88 | Target Price: | 103.47 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.69 | EPS Q/Q: | 7.20% | Payout: | 46.32% | Rel Volume: | 0.67 | Prev Close: | 76.06 |
| Sales Surprise: | 1.24% | EPS Surprise: | 4.09% | Sales Q/Q: | -1.20% | Earnings: | Apr 24 BMO | Avg Volume: | 17.12M | Price: | 77.23 |
| SMA20: | -3.04% | SMA50: | -8.11% | SMA200: | -21.87% | Undervalued: 33.98% | Volume: | 11,392,189 | Change: | 1.54% | |
Graham Classic formula value: 196.17
(P/E=8 * 1g) Min value: 121.22
(current P/E * 2g) Max value: 213.08
Average value: 176.82
About Merck & Co Inc
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.